Patient Care Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Patient Care Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Treatment
New findings reported from Keio University, Japan, describe advances in cancer treatment
January 7th, 2007
New cancer treatment findings from Keio University, Japan, described. Study 1: Scientists discuss in "Pharmacokinetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus" new findings in chemotherapy. "Arbekacin is widely used in Japan for the treatment of patients infected with methicillin-resistant Staphylococcus aureus (MRSA). In this study, we have determined the optimal concentration targets of arbekacin for both efficacy and safety," scientists in Tokyo, Japan report. "A pharmacokinetic-pharmacodynamic analysis was performed to relate exposure to the drug and...
Source: Patient Care Law Weekly (2007-01-07)
|
